Inventor · disambiguated record
David Michael Evans
Also filed as: EVANS DAVID · EVANS DAVID M · EVANS DAVID M A · EVANS DAVID MICHAEL
54 granted patents·44 pending applications·573 citations·filing 1980–2024
98Inventor score
Top patents by PatentIndex Score
98 records- 0197US11897102B2Hydraulic screw tensionerATLAS COPCO IND TECHNIQUE AB·Filed 2022·Granted Feb 13, 2024·3 cites·4 claims
- 0294US4441489AOrthopaedic splintsNAT RES DEV·Filed 1982·Granted Apr 10, 1984·270 cites·9 claims
- 0393US11058779B2Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infectionSIRNAOMICS INC·Filed 2016·Granted Jul 13, 2021·18 cites·20 claims
- 0491US10364238B2N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2015·Granted Jul 30, 2019·8 cites·16 claims
- 0591US9951068B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2017·Granted Apr 24, 2018·8 cites·21 claims
- 0691US9676769B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2014·Granted Jun 13, 2017·11 cites·9 claims
- 0791US9428498B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LTD·Filed 2014·Granted Aug 30, 2016·11 cites·16 claims
- 0890US10428066B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2018·Granted Oct 1, 2019·6 cites·25 claims
- 0989US10781181B2N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2015·Granted Sep 22, 2020·6 cites·36 claims
- 1089US10611758B2N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Granted Apr 7, 2020·4 cites·1 claims
- 1189US10221161B2Inhibitors of plasma kallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 5, 2019·13 cites·32 claims
- 1288US9533987B2Heterocyclic derivatesKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Jan 3, 2017·19 cites·27 claims
- 1388US6911467B2Antidiabetic agentsFERRING BV·Filed 2000·Granted Jun 28, 2005·19 cites·23 claims
- 1487US12147926B2Orchestrated intelligent supply chain optimizerOII INC·Filed 2022·Granted Nov 19, 2024·1 cites·20 claims
- 1587US12006500B2Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)SIRNAOMICS INC·Filed 2021·Granted Jun 11, 2024·2 cites·16 claims
- 1687US9642873B2Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic applicationLU PATRICK Y·Filed 2011·Granted May 9, 2017·7 cites·37 claims
- 1787US2025074903A1N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein InhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1886US10968223B2Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2020·Granted Apr 6, 2021·1 cites·24 claims
- 1985US12054714B2Peptide docking vehicle for targeted nucleic acid deliverySIRNAOMICS INC·Filed 2020·Granted Aug 6, 2024·1 cites·13 claims
- 2085US10590125B2CompoundsPROXIMAGEN LLC·Filed 2016·Granted Mar 17, 2020·3 cites·9 claims
- 2185US9670157B2Benzylamine derivativesKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Jun 6, 2017·13 cites·30 claims
- 2285US9012622B2Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancerLU PATRICK Y·Filed 2009·Granted Apr 21, 2015·7 cites·12 claims
- 2384US11512082B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LLC·Filed 2020·Granted Nov 29, 2022·1 cites·20 claims
- 2484US9738641B2Bicyclic inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Aug 22, 2017·13 cites·29 claims
- 2582US2023110165A1Substituted Imidazo[4,5-c]pyridine Compounds and Compositions ThereofPROXIMAGEN LLC·Filed 2022·Application pending·0 cites
- 2681US9580415B2CompoundsPROXIMAGEN LTD·Filed 2014·Granted Feb 28, 2017·9 cites·20 claims
- 2781US7169806B2Antidiabetic agentsFERRING BV·Filed 2005·Granted Jan 30, 2007·4 cites·17 claims
- 2880US10766897B2Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LLC·Filed 2019·Granted Sep 8, 2020·1 cites·27 claims
- 2979US9834513B2Benzylamine derivativesKALVISTA PHARMACEUTICALS LTD·Filed 2017·Granted Dec 5, 2017·4 cites·26 claims
- 3078US8183280B2FAP inhibitorsEVANS DAVID MICHAEL·Filed 2006·Granted May 22, 2012·8 cites·4 claims
- 3178US2025148398A1Orchestrated intelligent supply chain optimizerOII INC·Filed 2024·Application pending·0 cites
- 3277US2022289729A1N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein InhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 3376US11001578B2N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Granted May 11, 2021·0 cites·30 claims
- 3475US11084809B2N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Granted Aug 10, 2021·0 cites·15 claims
- 3574US7125863B2Inhibitors of dipeptidyl peptidase IVFERRING BV·Filed 2001·Granted Oct 24, 2006·7 cites·10 claims
- 3672US11198691B2N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Granted Dec 14, 2021·0 cites·24 claims
- 3769US7189728B2Inhibitors of dipeptidyl peptidase IVFERRING BV·Filed 2001·Granted Mar 13, 2007·4 cites·26 claims
- 3869US7144886B2Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agentsFERRING BV·Filed 2002·Granted Dec 5, 2006·4 cites·7 claims
- 3969US2023250080A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 4069US2025027086A1COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS USING MODIFIED siRNA-GEM AGENTSSIRNAOMICS INC·Filed 2024·Application pending·0 cites
- 4168US2024158794A1NUCLEOSIDE CONTAINING siRNAS FOR TREATING VIRAL DISEASESSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 4267US2024175032A1Compositions and methods for inhibiting expression of pcsk9SIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 4367US2022153724A1Inhibitors Of Plasma KallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 4467US2023392154A1Targeted nucleic acid therapy for hepatitis bSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 4566US9150574B2Enzyme inhibitor compoundsEVANS DAVID·Filed 2011·Granted Oct 6, 2015·1 cites·12 claims
- 4665US9227967B2Inhibitor compounds of semicarbazide-sensitive amine oxidasesEVANS DAVID·Filed 2011·Granted Jan 5, 2016·1 cites·37 claims
- 4765US2023355656A1Compositions and methods for treatment of skin cancersSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 4864US11613527B2Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Granted Mar 28, 2023·0 cites·46 claims
- 4964US2024108741A1COMBINATION siRNA AND PEPTIDE DOCKING VEHICLE (PDoV) COMPOSITIONS AND METHODS OF THEIR USE FOR IMPROVED REGULATION AND FUNCTIONALITYSIRNAOMICS INC·Filed 2023·Application pending·0 cites
- 5063US12354045B2Orchestrated intelligent supply chain optimizerOII INC·Filed 2020·Granted Jul 8, 2025·0 cites·15 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Michael Evans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →